Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The impact of microglial activation on blood-brain barrier in brain diseases.
Microglia: Dynamic Mediators of Synapse Development and Plasticity.
ATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry Study.
Longitudinal extensive transverse myelitis with cervical epidural haematoma following dengue virus infection.
Psychological and Neurobehavioral Disorders in MSA Health-Oriented, Rehabilitative Perspective.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
[Need for creating Polish registry of multiple sclerosis patients].
Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
Animal modeling an oligodendrogliopathy - multiple system atrophy.
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Characterization of a eukaryotic-like protein kinase, DspB, with an atypical catalytic loop motif from Myxococcus xanthus.
Contrast enhanced MR venography with gadofosveset trisodium: Evaluation of the intracranial and extracranial venous system.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Reliability and Repeatability of the Hoffmann Sign.
Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Pages
« first
‹ previous
…
695
696
697
698
699
700
701
702
703
…
next ›
last »